← Browse by Condition
Medical Condition
recurrent ovarian carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06292286
Recruiting
Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
Enrollment
18 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
NCT06295965
Recruiting
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Enrollment
2,000 pts
Location
United States
Sponsor
University of Washington
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...